Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 29Recruiting 13Unknown 11Active not recruiting 8Not yet recruiting 6Withdrawn 4Terminated 4Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Recurrence 1Prostatic Neoplasms 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leiomyoma 1Insulin Resistance 1Endometriosis 1Dementia 1Cognitive Dysfunction 1Alzheimer Disease 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Tablets × Clear all
NCT05568940 2024-05-30

eTAPE

McGill University Health Centre/Research Institute of the McGill University Health Centre

Withdrawn

Endometriosis, Leiomyoma

NCT04658849 2023-05-15

Insulin Resistance Following ADT for Prostate CA

St. Louis University

Phase EARLY_PHASE1 Withdrawn
Genitourinary

Insulin Resistance, Prostatic Neoplasms

NCT05330377 2023-04-25

GM-CLAG in Relapsed/Refractory FLT3-mutated AML

University of Kentucky

Phase 1 Withdrawn
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Boston University

Phase NA Withdrawn
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡